Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
Clinical trial NCT04518995 · COMPLETED
Trial details
- NCT number
- NCT04518995
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2022-04-19
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.